[Therapeutic effects of treatment with RFP on previously treated cases of pulmonary tuberculosis (author's transl)]. 1980

H Sakurai, and Y Watanabe, and M Yamanaka, and T Moriguchi, and K Fujii, and T Uenoyama

UI MeSH Term Description Entries
D007538 Isoniazid Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis. Isonicotinic Acid Hydrazide,Ftivazide,Isonex,Isonicotinic Acid Vanillylidenehydrazide,Phthivazid,Phthivazide,Tubazide,Acid Vanillylidenehydrazide, Isonicotinic,Hydrazide, Isonicotinic Acid,Vanillylidenehydrazide, Isonicotinic Acid
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

H Sakurai, and Y Watanabe, and M Yamanaka, and T Moriguchi, and K Fujii, and T Uenoyama
May 1979, Kekkaku : [Tuberculosis],
H Sakurai, and Y Watanabe, and M Yamanaka, and T Moriguchi, and K Fujii, and T Uenoyama
January 1979, Zhonghua jie he he hu xi xi ji bing za zhi = Chinese journal of tuberculosis and respiratory diseases,
H Sakurai, and Y Watanabe, and M Yamanaka, and T Moriguchi, and K Fujii, and T Uenoyama
November 1974, Kekkaku : [Tuberculosis],
H Sakurai, and Y Watanabe, and M Yamanaka, and T Moriguchi, and K Fujii, and T Uenoyama
June 1977, Kekkaku : [Tuberculosis],
H Sakurai, and Y Watanabe, and M Yamanaka, and T Moriguchi, and K Fujii, and T Uenoyama
January 1974, Repura. Leprosy,
H Sakurai, and Y Watanabe, and M Yamanaka, and T Moriguchi, and K Fujii, and T Uenoyama
January 1974, Repura. Leprosy,
H Sakurai, and Y Watanabe, and M Yamanaka, and T Moriguchi, and K Fujii, and T Uenoyama
January 1979, Praxis und Klinik der Pneumologie,
H Sakurai, and Y Watanabe, and M Yamanaka, and T Moriguchi, and K Fujii, and T Uenoyama
January 1974, Kekkaku : [Tuberculosis],
H Sakurai, and Y Watanabe, and M Yamanaka, and T Moriguchi, and K Fujii, and T Uenoyama
January 1979, Zhonghua jie he he hu xi xi ji bing za zhi = Chinese journal of tuberculosis and respiratory diseases,
H Sakurai, and Y Watanabe, and M Yamanaka, and T Moriguchi, and K Fujii, and T Uenoyama
October 1974, Kekkaku : [Tuberculosis],
Copied contents to your clipboard!